Latanoprost Noridem

Latanoprost, the active ingredient in Latanoprost Noridem, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It lowers intra‑ocular pressure and is employed in the management of open‑angle glaucoma and ocular hypertension in adult patients.

GNH USA supplies Latanoprost Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory‑compliant documentation for global distribution.

Latanoprost is used to treat ocular conditions characterized by elevated intra‑ocular pressure.

Open‑angle glaucoma: reduces intra‑ocular pressure to slow disease progression. Ocular hypertension: lowers intra‑ocular pressure to prevent development of glaucoma. Secondary open‑angle glaucoma: decreases pressure to protect the optic nerve.

Latanoprost may cause ocular and systemic reactions, most of which are mild and transient.

Common Side Effects: - Eye redness or hyperemia - Increased eyelash length and density - Darkening of the iris color - Eye irritation or foreign‑body sensation - Blurred vision - Mild eye pain

Serious or Rare Side Effects: - Severe eye inflammation (uveitis) - Allergic reactions such as swelling of the eyelid or conjunctiva - Unexpected rise in intra‑ocular pressure - Corneal edema or clouding - Vision loss - Persistent eye pain requiring medical attention

Before using Latanoprost, consider the following safety measures.

Pregnancy: consult a healthcare professional; safety data are limited. Breastfeeding: discuss risks with a physician; the drug may be excreted in milk. Existing eye conditions: inform the prescriber of any ocular infections or inflammation. Contact lens wearers: remove lenses before instillation and wait at least 15 minutes before reinserting. Allergies: avoid use if known hypersensitivity to prostaglandin analogs. Store at room temperature: keep in the original container, protect from light and moisture.

Latanoprost can interact with other ocular or systemic agents, affecting efficacy or safety.

Major Interactions (Avoid): - Concomitant use with other prostaglandin analog eye drops: risk of additive ocular side effects. - Nonsteroidal anti‑inflammatory eye drops: may reduce Latanoprost efficacy. - Systemic carbonic anhydrase inhibitors: additive intra‑ocular pressure lowering.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: monitor intra‑ocular pressure for excessive reduction. - Alpha‑agonist eye drops: observe for synergistic pressure‑lowering effects. - Systemic antihistamines: may exacerbate dry‑eye symptoms. - Topical corticosteroids: may diminish Latanoprost’s pressure‑lowering action. - Anticholinergic eye drops: watch for changes in pupil size and accommodation.